<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=16816"><dc:title>An analysis of the optimal capital structure changes of selected generic pharmaceutical companies during the crisis</dc:title><dc:creator>Gorenc,	Tanja	(Avtor)
	</dc:creator><dc:creator>Berk,	Aleš	(Mentor)
	</dc:creator><dc:subject>farmacevtska industrija</dc:subject><dc:subject>industrijsko podjetje</dc:subject><dc:subject>kapital</dc:subject><dc:subject>struktura</dc:subject><dc:subject>optimizacija</dc:subject><dc:subject>krize</dc:subject><dc:subject>primeri</dc:subject><dc:subject>Krka</dc:subject><dc:subject/><dc:publisher>[T. Gorenc]</dc:publisher><dc:date>2012</dc:date><dc:date>2014-07-11 13:49:06</dc:date><dc:type>Magistrsko delo/naloga</dc:type><dc:identifier>16816</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>